The Computational Analysis Facility provides access to and expertise in high-performance computers and software for biological research in the institution. The facility, located on the thirteenth floor of the Houston Main Building, provides computer network access through Ethernet connections to all components of M.D. Anderson. Initially, the facility focused on computer support for the analysis of sequence data, including supplying the requisite programs for the manipulation of such data and database-searching technology. This support is being extended to providing software and expertise for molecular modeling of sequence data. While these types of analyses are necessary for conducting research in molecular biology today, few laboratories can afford to devote a person to the full- time activities required to remain current in this yield. Moreover, even few laboratories are able to support a person to find, install, and evaluate programs in the public domain that might be critical to one phase of research. Finally, few individual laboratories can afford the software licensing fees and the special computers required for analyses such as molecular modeling. Moreover, assistance with packages that are used only occasionally in a laboratory can be better obtained by a central resource facility like the CAF. At a lower level, the facility acts as a general ombudsman for general questions on computing and computers. Traditionally, the facility has measured its use by the number of central processing unit (CPU) hours used by all users. From December, 1993 to June, 1997, individuals in 21 Anderson departments used 3,866 CPU hours. In addition, the Facility teaches a graduate course on sequence analysis with a specific format making it easy for researchers to attend only the parts relevant to their research. This and other CAF activities are advertised through a newsletter and a World Wide Web page. In the future, the Facility will extend its computer support into related areas in which specialized software running on high-performance computers may be of use to a large number of users, such as three-dimensional analysis of confocal microscopy images obtained in the Automated Cytometry and Cell Sorter Laboratory/Confocal Microscopy and Image Analysis Facility. The policies of the Computational Analysis Facility are overseen by a committee comprised of Drs. de Crombrugghe, Marsha Frazier (Gastrointestinal Oncology and Digestive Diseases), and R. Allen White (biomathematics).

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
3P30CA016672-26S2
Application #
6506687
Study Section
Project Start
2001-09-28
Project End
2002-06-30
Budget Start
Budget End
Support Year
26
Fiscal Year
2001
Total Cost
Indirect Cost
Name
University of Texas MD Anderson Cancer Center
Department
Type
DUNS #
001910777
City
Houston
State
TX
Country
United States
Zip Code
77030
Chang, Geraldine H; Kurzrock, Razelle; Tran, Lisa et al. (2018) TP53 mutations and number of alterations correlate with maximum standardized uptake value (SUVmax) determined by positron emission tomography/computed tomography (PET/CT) [18F] fluorodeoxyglucose (18F-FDG PET). Oncotarget 9:14306-14310
Abaza, Yasmin; Cortes, Jorge; Ravandi, Farhad et al. (2018) Prognostic significance of hyperdiploidy in adult acute myeloid leukemia. Am J Hematol 93:E357-E360
Ellrott, Kyle; Bailey, Matthew H; Saksena, Gordon et al. (2018) Scalable Open Science Approach for Mutation Calling of Tumor Exomes Using Multiple Genomic Pipelines. Cell Syst 6:271-281.e7
White, Matthew C; Schroeder, Rebecca D; Zhu, Keyi et al. (2018) HRI-mediated translational repression reduces proteotoxicity and sensitivity to bortezomib in human pancreatic cancer cells. Oncogene 37:4413-4427
Abaza, Yasmin; Hidalgo-Lopez, Juliana E; Verstovsek, Srdan et al. (2018) Phase I study of ruxolitinib in previously treated patients with low or intermediate-1 risk myelodysplastic syndrome with evidence of NF-kB activation. Leuk Res 73:78-85
McGrail, Daniel J; Federico, Lorenzo; Li, Yongsheng et al. (2018) Multi-omics analysis reveals neoantigen-independent immune cell infiltration in copy-number driven cancers. Nat Commun 9:1317
Li, Carrie J; Jiang, Changying; Liu, Yang et al. (2018) Pleiotropic Action of Novel Bruton's Tyrosine Kinase Inhibitor BGB-3111 in Mantle Cell Lymphoma. Mol Cancer Ther :
Morita, Kiyomi; Kantarjian, Hagop M; Wang, Feng et al. (2018) Clearance of Somatic Mutations at Remission and the Risk of Relapse in Acute Myeloid Leukemia. J Clin Oncol 36:1788-1797
Raber, Benjamin; Bea, Vivian J; Bedrosian, Isabelle (2018) How Does MR Imaging Help Care for My Breast Cancer Patient? Perspective of a Surgical Oncologist. Magn Reson Imaging Clin N Am 26:281-288
Li, Roger; Metcalfe, Michael J; Ferguson 3rd, James E et al. (2018) Effects of thiazolidinedione in patients with active bladder cancer. BJU Int 121:244-251

Showing the most recent 10 out of 12418 publications